STING1 and urinary bladder cancer: Moreover, by multidisciplinary approach, we clarify the inner mechanism; explore the potential of Trp restriction dietary or pharmacologic inhibition of related molecules in sensitizing bladder cancer to chemo-drugs or STING agonist; and verify the clinical relevance with related genes, metabolic pathways, or metabolites.